50 related articles for article (PubMed ID: 12388422)
1. Bradykinin reduces growth factor-induced glomerular ERK1/2 phosphorylation.
Cellier E; Mage M; Duchêne J; Pécher C; Couture R; Bascands JL; Girolami JP
Am J Physiol Renal Physiol; 2003 Feb; 284(2):F282-92. PubMed ID: 12388422
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of IGF-I-induced Erk 1 and 2 activation and mitogenesis in mesangial cells by bradykinin.
Alric C; Pecher C; Cellier E; Schanstra JP; Poirier B; Chevalier J; Bascands JL; Girolami JP
Kidney Int; 2002 Aug; 62(2):412-21. PubMed ID: 12110002
[TBL] [Abstract][Full Text] [Related]
3. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
Greco S; Muscella A; Elia MG; Romano S; Storelli C; Marsigliante S
J Cell Physiol; 2004 Oct; 201(1):84-96. PubMed ID: 15281091
[TBL] [Abstract][Full Text] [Related]
4. Endothelium-derived nitric oxide (NO) activates the NO-epidermal growth factor receptor-mediated signaling pathway in bradykinin-stimulated angiogenesis.
Moraes MS; Costa PE; Batista WL; Paschoalin T; Curcio MF; Borges RE; Taha MO; Fonseca FV; Stern A; Monteiro HP
Arch Biochem Biophys; 2014 Sep; 558():14-27. PubMed ID: 24960080
[TBL] [Abstract][Full Text] [Related]
5. B2 receptor activation reduces Erk1 and Erk2 phosphorylation induced by insulin-like growth factor-1, platelet-derived growth factor-BB, and high glucose in rat isolated glomeruli.
Cellier E; Duchêne J; Pécher C; Alric C; Bascands JL; Schanstra JP; Girolami JP
Can J Physiol Pharmacol; 2002 Apr; 80(4):341-5. PubMed ID: 12025970
[TBL] [Abstract][Full Text] [Related]
6. Bradykinin inhibits high glucose- and growth factor-induced collagen synthesis in mesangial cells through the B2-kinin receptor.
Blaes N; Pécher C; Mehrenberger M; Cellier E; Praddaude F; Chevalier J; Tack I; Couture R; Girolami JP
Am J Physiol Renal Physiol; 2012 Jul; 303(2):F293-303. PubMed ID: 22573379
[TBL] [Abstract][Full Text] [Related]
7. ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats.
Allard J; Buléon M; Cellier E; Renaud I; Pecher C; Praddaude F; Conti M; Tack I; Girolami JP
Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1083-92. PubMed ID: 17596523
[TBL] [Abstract][Full Text] [Related]
8. Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells.
Wang Z; Yang H; Tachado SD; Capó-Aponte JE; Bildin VN; Koziel H; Reinach PS
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5267-75. PubMed ID: 17122112
[TBL] [Abstract][Full Text] [Related]
9. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
Shah BH; Olivares-Reyes JA; Catt KJ
Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928
[TBL] [Abstract][Full Text] [Related]
10. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
Wang X; Weng LP; Yu Q
Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction.
Hua H; Munk S; Whiteside CI
Am J Physiol Renal Physiol; 2003 Feb; 284(2):F303-12. PubMed ID: 12388423
[TBL] [Abstract][Full Text] [Related]
14. Induction of B1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation.
Mage M; Pécher C; Neau E; Cellier E; Dos Reiss ML; Schanstra JP; Couture R; Bascands JL; Girolami JP
Can J Physiol Pharmacol; 2002 Apr; 80(4):328-33. PubMed ID: 12025968
[TBL] [Abstract][Full Text] [Related]
15. Delay in serum stimulation of Erk activity caused by oncogenic transformation.
Greulich H; Reichman C; Hanafusa H
Oncogene; 1996 Apr; 12(8):1689-95. PubMed ID: 8622889
[TBL] [Abstract][Full Text] [Related]
16. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.
Li B; Yang L; Shen J; Wang C; Jiang Z
Anesth Analg; 2007 Oct; 105(4):1034-41, table of contents. PubMed ID: 17898384
[TBL] [Abstract][Full Text] [Related]
17. Collagenase-2 and -3 mediate epidermal growth factor receptor transactivation by bradykinin B2 receptor in kidney cells.
Mukhin YV; Gooz M; Raymond JR; Garnovskaya MN
J Pharmacol Exp Ther; 2006 Sep; 318(3):1033-43. PubMed ID: 16717107
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms through which bradykinin promotes glomerular injury in diabetes.
Tan Y; Wang B; Keum JS; Jaffa AA
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F483-92. PubMed ID: 15692059
[TBL] [Abstract][Full Text] [Related]
19. [30 years: Happy birthday, GPCR. The bradykinin B2 receptor: an alternative and antiproliferative pathway].
Duchêne J; Schanstra J; Cellier E; Bascands JL; Girolami JP
Nephrologie; 2002; 23(1):39-41. PubMed ID: 11908480
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of epidermal growth factor receptor at serine 1047 in cultured lung alveolar epithelial cells by bradykinin B2 receptor stimulation.
Izumi S; Higa-Nakamine S; Nishi H; Torihara H; Uehara A; Sugahara K; Kakinohana M; Yamamoto H
Pulm Pharmacol Ther; 2018 Feb; 48():53-61. PubMed ID: 28899709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
